The lives of people with cancer are measured in birthdays, graduations, weddings and anniversaries.
Every day is valuable to patients and to their loved ones.
Life-Years Saved from Cancer Since 1990
September 10, 2014 06:58 PM EDT 0 comments
Members of Congress were further alerted to many of the issues preventing efficient clinical trials and patient access to innovative medication during a roundtable discussion convened on Wednesday, September 10, 2014 by the House Committee on Energy and Commerce as part of the non-partisan 21st Century Cures initiative. While the conversation was not limited to cancer medication, the event raised several key points about the ongoing struggle to streamline the clinical trial process.Read More
August 20, 2014 01:33 PM EDT 0 comments
An editorial published yesterday in the Wall Street Journal argues that calls to reduce prices of new drugs is the latest threat to medical innovation. With pharmaceutical companies subject to a seemingly endless approval process and a narrow window of profitability before their patents lapse (resulting in affordable generic drugs which now account for 86% of total filled prescriptions), the piece claims that the ability to set their own prices is a key motivating force in driving medical innovation.Read More
August 18, 2014 03:21 PM EDT 0 comments
A strongly worded letter to Health and Human Services Secretary Sylvia Mathews Burwell, signed by more than 300 patient advocacy groups, accuses insurance providers of employing discriminatory policies designed to limit patient access to certain essential drugs – despite the provisions outlined in the Affordable Care Act.Read More
August 18, 2014 01:43 PM EDT 0 comments
Innovative treatments not only save lives – they save money. A newly published editorial in Forbes by pharmaceutical executive and chemist John Lechleiter illustrates how past medical triumphs, such as the Salk polio vaccine and anti-retroviral treatments for HIV, effectively curbed escalating costs.Read More
August 5, 2014 11:41 AM EDT 0 comments
Until now, cancer patients in Maine (as in several other states and those covered by federal policies) who have wanted to utilize oral chemotherapy treatments have faced substantially higher co-pays than the intravenous option.Read More